Cited by 86Telomeres, Telomerase, and SenescenceGenetics, Aging, and Longevity in Model OrganismsCancer-related Molecular Pathways

Replicative senescence revisited.

Marcotte, R., Wang, E.·2002·The Journals of Gerontology Series A: Biological Sciences and Medical Sciences

Abstract

Forty years after its discovery, replicative senescence remains a rich source of information about cell-cycle regulation and the progression from a normal to a transformed phenotype. Effectors of this growth-arrested state are being discovered at a great pace. This review discusses the latest findings on the players responsible for establishing replicative senescence, as well as the associated telomere shortening.

Integrity signals

Registry

Crossref · 10.1093/gerona/57.7.b257

Cites

183 of 183 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Marcotte, R., & Wang, E.
Affiliations
Jewish General Hospital (CA)
Corresponding author
Marcotte, R.
Venue
The Journals of Gerontology Series A: Biological Sciences and Medical Sciences
Published
2002-07-01
Volume
57
Issue
7
Pages
B257-B269
ISSN
  • 1079-5006 (ISSN-L)
  • 1758-535X
OpenAlex
W2137592705
Cited by
86
References
183
Citations by year
2026: 2 · 2025: 1 · 2024: 1 · 2023: 4 · 2022: 13 · 2021: 3 · 2020: 2 · 2019: 3 · 2018: 2 · 2017: 1 · 2016: 4 · 2015: 6 · 2014: 3 · 2013: 5 · 2012: 3
FWCI
0.61
Type
journal article
Language
en
Open access
closed
Locations
  • The Journals of Gerontology Series A (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5r01ag007444-05)
  • National Institute on Aging (R01AG 07444)
Topics
  • Health Sciences › Medicine › Physiology › Telomeres, Telomerase, and Senescence
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Keywords
replicative senescence, cell cycle regulation, telomere shortening, cell transformation, aging
MeSH terms
Animals, Cell Cycle, Humans, Tumor Suppressor Protein p53, Retinoblastoma Protein, Cyclins, Telomere, Cellular Senescence, Cyclin-Dependent Kinase Inhibitor p16, Tumor Suppressor Protein p14ARF, Cyclin-Dependent Kinase Inhibitor p21

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review